Periodic transaction disclosures · 2026

Trading on America

Congressional stock activity in the available House Clerk and Senate eFD PTR rows. Count activity; inspect the disclosure. Do not confuse a disclosed range with a price, profit, or a complete portfolio.

Disclosure interval: January 1–November 5, 2026, by transaction date
Buy / sell lines: 3,223 across 130 current members

Disclosure coverage: 1,987 House rows / 1,258 Senate rows with a 2026 transaction date
Ranking: Lines first; midpoint dollars second; member count third

Hottest stocks — top 25

Ranked by 2026 buy/sell disclosure line count, not presumed return or conviction. Includes individual-company common/common-equivalent stocks; excludes options, funds, ETFs, trusts and exchange-only rows. Ties break on estimated midpoint dollars, then member count. Read each linked filing for the precise asset type and context.

25 ticker-bearing individual-company stock rows, based on available official periodic disclosures through November 5, 2026.
#	Company / ticker	Buy vs sell lines	Members	Lines	Est. midpoint sum	Official disclosure
1	Apple Inc. - Common Stock `AAPL`	15 buy / 14 sell	18	29	$623,515	U.S. Senate eFD disclosure
2	Home Depot, Inc. `HD`	11 buy / 12 sell	11	23	$275,512	U.S. Senate eFD disclosure
3	Advanced Micro Devices, Inc. `AMD`	11 buy / 3 sell	6	14	$136,507	U.S. Senate eFD disclosure
4	Hubbell Inc Common Stock `HUBB`	14 buy / 0 sell	2	14	$112,007	U.S. Senate eFD disclosure
5	AT&T Inc. `T`	7 buy / 5 sell	7	12	$120,506	U.S. Senate eFD disclosure
6	Intuit Inc. - Common Stock `INTU`	2 buy / 9 sell	7	11	$88,006	U.S. Senate eFD disclosure
7	Palo Alto Networks, Inc. `PANW`	8 buy / 3 sell	6	11	$88,006	U.S. Senate eFD disclosure
8	Visa Inc. `V`	6 buy / 4 sell	6	10	$104,505	U.S. Senate eFD disclosure
9	GE Aerospace Common Stock `GE`	5 buy / 4 sell	6	9	$96,505	U.S. Senate eFD disclosure
10	Veralto Corp Common Stock `VLTO`	5 buy / 4 sell	2	9	$72,005	U.S. House Clerk disclosure
11	NVIDIA Corporation - Common Stock `NVDA`	3 buy / 5 sell	4	8	$371,504	U.S. Senate eFD disclosure
12	Microsoft Corporation - Common Stock `MSFT`	6 buy / 2 sell	5	8	$113,004	U.S. Senate eFD disclosure
13	Amgen Inc. - Common Stock `AMGN`	3 buy / 5 sell	3	8	$88,504	U.S. Senate eFD disclosure
14	Kenvue Inc. Common Stock `KVUE`	3 buy / 5 sell	3	8	$88,504	U.S. Senate eFD disclosure
15	Progressive Corporation `PGR`	5 buy / 3 sell	3	8	$88,504	U.S. Senate eFD disclosure
16	Pepsico, Inc. `PEP`	4 buy / 4 sell	6	8	$64,004	U.S. Senate eFD disclosure
17	Corpay, Inc. Common Stock `CPAY`	0 buy / 8 sell	1	8	$64,004	U.S. House Clerk disclosure
18	Chubb Limited Common Stock `CB`	4 buy / 3 sell	5	7	$56,004	U.S. Senate eFD disclosure
19	Biogen Inc. - Common Stock `BIIB`	5 buy / 2 sell	4	7	$56,004	U.S. Senate eFD disclosure
20	BlackRock, Inc. Common Stock `BLK`	1 buy / 6 sell	3	7	$56,004	U.S. Senate eFD disclosure
21	Flex Ltd. - Ordinary Shares `FLEX`	0 buy / 7 sell	1	7	$56,004	U.S. House Clerk disclosure
22	Goldman Sachs Group, Inc. `GS`	5 buy / 1 sell	5	6	$72,503	U.S. Senate eFD disclosure
23	Tesla, Inc. - Common Stock `TSLA`	5 buy / 1 sell	2	6	$72,503	U.S. Senate eFD disclosure
24	Adobe Inc. - Common Stock `ADBE`	2 buy / 4 sell	4	6	$48,003	U.S. Senate eFD disclosure
25	Cencora, Inc. Common Stock `COR`	4 buy / 2 sell	2	6	$48,003	U.S. Senate eFD disclosure

Each ticker links to one example underlying PTR, not every filing represented. Search House Clerk disclosures or Senate eFD for complete member histories. The full underlying export is on Downloads, with its ordinary range labels and specific record links.

YTD disclosed-stock activity versus the S&P 500

Model baseline: January 1, 2026
Valuation close: November 5, 2026 ET

S&P 500 price-only YTD: 7.42%
Matched benchmark: Same dated dollar flows

Estimated disclosed-stock flows — strongest S&P spreads

Each value below is a model estimate in percent or percentage points. Rank only within this limited covered sample.

Highest estimated relative spreads

Highest estimated relative spreads within fully price-matched, purchase-backed stock disclosures only. Not member or household performance.
Member	Raw stock lines / tickers	Buy midpoint sum	Synthetic flow return	Flow-matched S&P	Estimated spread vs S&P
John Fetterman	7 / 5	$48,003	44.46%	13.19%	+31.27 pp
Gary C. Peters	5 / 5	$56,502	22.86%	0.67%	+22.19 pp
Ed Case	3 / 1	$24,002	19.89%	-0.02%	+19.90 pp
Cleo Fields	4 / 1	$32,002	17.12%	-1.05%	+18.18 pp
Jerry Moran	2 / 1	$40,501	16.75%	-0.57%	+17.32 pp

Lowest estimated relative spreads

Lowest estimated relative spreads within fully price-matched, purchase-backed stock disclosures only. Not member or household performance.
Member	Raw stock lines / tickers	Buy midpoint sum	Synthetic flow return	Flow-matched S&P	Estimated spread vs S&P
Sheldon Whitehouse	21 / 16	$40,501	-55.87%	1.54%	-57.40 pp
W. Gregory Steube	1 / 1	$8,001	-18.38%	11.00%	-29.38 pp
Rick W. Allen	2 / 2	$8,001	-26.22%	-2.52%	-23.71 pp
Lisa C. McClain	2 / 2	$16,001	-24.26%	-3.89%	-20.37 pp
April McClain Delaney	28 / 5	$128,008	-17.41%	0.60%	-18.01 pp

All qualified synthetic-flow estimates (26)

All qualified member estimates in this limited model, sorted by estimated spread against the same-date S&P cash-flow model. Rank only within this limited covered sample.
Member	Lines / tickers	Buy midpoint sum	Synthetic flow return	Flow-matched S&P	Spread
John Fetterman	7 / 5	$48,003	44.46%	13.19%	+31.27 pp
Gary C. Peters	5 / 5	$56,502	22.86%	0.67%	+22.19 pp
Ed Case	3 / 1	$24,002	19.89%	-0.02%	+19.90 pp
Cleo Fields	4 / 1	$32,002	17.12%	-1.05%	+18.18 pp
Jerry Moran	2 / 1	$40,501	16.75%	-0.57%	+17.32 pp
Shelley Moore Capito	19 / 15	$32,002	15.38%	-0.82%	+16.20 pp
Jared Moskowitz	21 / 10	$104,007	21.06%	7.39%	+13.67 pp
John J. McGuire III	6 / 3	$8,001	18.17%	6.91%	+11.25 pp
David J. Taylor	35 / 8	$192,012	11.46%	0.73%	+10.73 pp
John Boozman	50 / 39	$224,014	8.57%	1.45%	+7.12 pp
Lloyd Doggett	3 / 1	$24,002	8.97%	2.62%	+6.35 pp
Scott Franklin	3 / 2	$16,001	0.37%	-4.19%	+4.56 pp
Julia Letlow	13 / 12	$40,003	3.19%	0.62%	+2.56 pp
Mitch McConnell	3 / 1	$48,502	0.58%	-1.83%	+2.42 pp
Maria Elvira Salazar	12 / 8	$40,003	13.16%	11.75%	+1.41 pp
Thomas H. Kean, Jr.	7 / 3	$48,003	2.49%	4.48%	-1.99 pp
Dan Newhouse	9 / 9	$32,002	-3.20%	0.00%	-3.20 pp
Lucy McBath	10 / 7	$16,001	4.25%	10.35%	-6.11 pp
Michael A. Rulli	4 / 4	$16,001	-10.31%	-2.60%	-7.71 pp
Jonathan L. Jackson	4 / 3	$24,002	0.53%	10.15%	-9.62 pp
John W. Hickenlooper	5 / 5	$250,001	-13.50%	0.02%	-13.51 pp
April McClain Delaney	28 / 5	$128,008	-17.41%	0.60%	-18.01 pp
Lisa C. McClain	2 / 2	$16,001	-24.26%	-3.89%	-20.37 pp
Rick W. Allen	2 / 2	$8,001	-26.22%	-2.52%	-23.71 pp
W. Gregory Steube	1 / 1	$8,001	-18.38%	11.00%	-29.38 pp
Sheldon Whitehouse	21 / 16	$40,501	-55.87%	1.54%	-57.40 pp

Not enough information to estimate a person’s whole portfolio. 22 of 48 candidates are excluded with no identified 2026 stock purchase in the model set or an unavailable required stock/date price. No zero-return fallback is used. Some fully priced members have only a few stock lines. Different disclosure timing can move both measures. Sales requiring undisclosed pre-2026 lots are not modeled; the incremental sample does not claim to set the member’s actual cost basis or opening holdings.

Full transparent methodology and limitations

Use identifiable individual-company common/common-equivalent 2026 buy/sell lines, excluding options, funds, ETFs, trusts and exchanges. Combine midpoint ranges for same-person, same-ticker, same-date transactions in the same direction.
Divide those midpoints by the latest available daily split-adjusted closing price on or before the transaction date to estimate shares. This is not an observed execution or share count.
Compute synthetic buys and sales against this disclosed 2026 incremental pool only. If a sale exceeds available modeled shares, excess proceeds and their benchmark sale are excluded rather than inventing an opening portfolio. Members with no qualifying identified-stock purchase or with an incomplete required price path are omitted from the comparison.
Mark positions through the November 5 close and add remaining uncommitted cash. Divide final synthetic value by the buy-midpoint budget and subtract 1 for the return. Dividends, fees, taxes, exact net buys, private holdings, cash yields, and unincluded family ownership are not measured.
Start with hypothetical cash equal to the sum of 2026 model buy midpoints (not actual member cash). Buy synthetic shares at disclosed-date closes and mirror those dollar buys in the S&P 500 price index. Sales draw down synthetic holdings up to the 2026 modeled quantity; sales beyond those lot amounts are outside this incremental model. Uncommitted cash has no yield. Valuation uses November 5 closes; no unreported opening portfolio is invented. Both price-model measures exclude dividends; deltas are percentage points, not dollar gains or relative returns.

The aggregate year-to-date S&P price change is for context; a member’s matched benchmark turns over at the staged disclosure dates. A higher number here implies neither wrongdoing nor skill. This is not investment advice. Read the raw House Clerk / Senate eFD filings on the member’s Trades view.

Return to profiles Open a profile’s Trades view for individual rows. Trading method notes